全文获取类型
收费全文 | 19813篇 |
免费 | 1340篇 |
国内免费 | 99篇 |
专业分类
耳鼻咽喉 | 271篇 |
儿科学 | 434篇 |
妇产科学 | 421篇 |
基础医学 | 2479篇 |
口腔科学 | 616篇 |
临床医学 | 1637篇 |
内科学 | 5060篇 |
皮肤病学 | 444篇 |
神经病学 | 1695篇 |
特种医学 | 465篇 |
外科学 | 3367篇 |
综合类 | 131篇 |
一般理论 | 8篇 |
预防医学 | 1179篇 |
眼科学 | 611篇 |
药学 | 1053篇 |
1篇 | |
中国医学 | 40篇 |
肿瘤学 | 1340篇 |
出版年
2023年 | 136篇 |
2022年 | 101篇 |
2021年 | 632篇 |
2020年 | 371篇 |
2019年 | 605篇 |
2018年 | 750篇 |
2017年 | 433篇 |
2016年 | 491篇 |
2015年 | 612篇 |
2014年 | 832篇 |
2013年 | 1014篇 |
2012年 | 1721篇 |
2011年 | 1770篇 |
2010年 | 926篇 |
2009年 | 855篇 |
2008年 | 1386篇 |
2007年 | 1441篇 |
2006年 | 1308篇 |
2005年 | 1178篇 |
2004年 | 1020篇 |
2003年 | 859篇 |
2002年 | 804篇 |
2001年 | 111篇 |
2000年 | 92篇 |
1999年 | 132篇 |
1998年 | 157篇 |
1997年 | 106篇 |
1996年 | 90篇 |
1995年 | 126篇 |
1994年 | 112篇 |
1993年 | 112篇 |
1992年 | 89篇 |
1991年 | 64篇 |
1990年 | 48篇 |
1989年 | 51篇 |
1988年 | 48篇 |
1987年 | 41篇 |
1986年 | 48篇 |
1985年 | 37篇 |
1984年 | 54篇 |
1983年 | 49篇 |
1982年 | 57篇 |
1981年 | 59篇 |
1980年 | 38篇 |
1979年 | 33篇 |
1978年 | 29篇 |
1977年 | 30篇 |
1976年 | 24篇 |
1974年 | 23篇 |
1973年 | 23篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
6.
Milan Milojevic Patrick W. Serruys Joseph F. Sabik David E. Kandzari Erick Schampaert Ad J. van Boven Ferenc Horkay Imre Ungi Samer Mansour Adrian P. Banning David P. Taggart Manel Sabaté Anthony H. Gershlick Andrzej Bochenek Jose Pomar Nicholas J. Lembo Nicolas Noiseux John D. Puskas Arie Pieter Kappetein 《Journal of the American College of Cardiology》2019,73(13):1616-1628
Background
The randomized EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial reported a similar rate of the 3-year composite primary endpoint of death, myocardial infarction (MI), or stroke in patients with left main coronary artery disease (LMCAD) and site-assessed low or intermediate SYNTAX scores treated with percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). Whether these results are consistent in high-risk patients with diabetes, who have fared relatively better with CABG in most prior trials, is unknown.Objectives
In this pre-specified subgroup analysis from the EXCEL trial, the authors sought to examine the effect of diabetes in patients with LMCAD treated with PCI versus CABG.Methods
Patients (N = 1,905) with LMCAD and site-assessed low or intermediate CAD complexity (SYNTAX scores ≤32) were randomized 1:1 to PCI with everolimus-eluting stents versus CABG, stratified by the presence of diabetes. The primary endpoint was the rate of a composite of all-cause death, stroke, or MI at 3 years. Outcomes were examined in patients with (n = 554) and without (n = 1,350) diabetes.Results
The 3-year composite primary endpoint was significantly higher in diabetic compared with nondiabetic patients (20.0% vs. 12.9%; p < 0.001). The rate of the 3-year primary endpoint was similar after treatment with PCI and CABG in diabetic patients (20.7% vs. 19.3%, respectively; hazard ratio: 1.03; 95% confidence interval: 0.71 to 1.50; p = 0.87) and nondiabetic patients (12.9% vs. 12.9%, respectively; hazard ratio: 0.98; 95% confidence interval: 0.73 to 1.32; p = 0.89). All-cause death at 3 years occurred in 13.6% of PCI and 9.0% of CABG patients (p = 0.046), although no significant interaction was present between diabetes status and treatment for all-cause death (p = 0.22) or other endpoints, including the 3-year primary endpoint (p = 0.82) or the major secondary endpoints of death, MI, or stroke at 30 days (p = 0.61) or death, MI, stroke, or ischemia-driven revascularization at 3 years (p = 0.65).Conclusions
In the EXCEL trial, the relative 30-day and 3-year outcomes of PCI with everolimus-eluting stents versus CABG were consistent in diabetic and nondiabetic patients with LMCAD and site-assessed low or intermediate SYNTAX scores.(Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization [EXCEL]; NCT01205776) 相似文献7.
8.
Leopoldo Pérez de Isla Raquel Arroyo-Olivares Ovidio Muñiz-Grijalvo José Luis Diaz-Díaz Daniel Zambón Francisco Fuentes Juan F. Sánchez Muñoz-Torrero Juan Diego Mediavilla Aurora González-Estrada Jose Pablo Miramontes-González Raimundo de Andrés Marta Mauri Daniel Mosquera José M. Cepeda Lorena Suárez Miguel Ángel Barba-Romero Rosa Argüeso Pilar Álvarez-Baños Pedro Mata 《Journal of clinical lipidology》2019,13(6):989-996
9.
10.
Tarun Shankar Choudhary Akanksha Srivastava Ranadip Chowdhury Sunita Taneja Rajiv Bahl Jose Martines Maharaj Kishan Bhan Nita Bhandari 《Maternal & child nutrition》2019,15(4)
Burden and risk factors for wasting in the first 6 months of life among Indian children are not well documented. We used data from India's National Family Health Survey 4 to estimate the prevalence of severe wasting (weight for length < ‐3 SD) among 18,898 infants under 6 months of age. We also examined the association of severe wasting with household, maternal, and child‐related factors using multivariable logistic regression analysis. Prevalence of severe wasting among infants less than 6 months of age was 14.8%, ranging from 3.5 to 21% across states. Low birth weight (<2,500 g; adjusted odds ratio [AOR] 1.40, 95% CI [1.19, 1.65]), nonutilization of supplementary nutrition by mother during lactation (AOR 1.23, 95% CI [1.05, 1.43]), and anthropometric assessment during summer (AOR 1.37, 95% CI [1.13, 1.65]) and monsoon months (AOR 1.53, 95% CI [1.20, 1.95]) were associated with higher odds of severe wasting. Infants aged 2 to 3 months (AOR 0.78, 95% CI [0.66, 0.93]) and 4 to 5 months (AOR 0.65, 95% CI [0.55, 0.73]) had lower odds of severe wasting as compared with the 0‐ to 1‐month category. This analysis reveals a high burden of severe wasting in infants less than 6 months in India. Preventive interventions must be targeted at reducing low birth weight due to fatal growth restriction and prematurity. Appropriate care practices at facilities and postdischarge with extra attention to those born small and sick can prevent further deterioration in nutritional status. 相似文献